CIK 0001093557 · Large accelerated filer
DEXCOM INC
Sign in to watch- Ticker
- DXCM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330857544
- Phone
- 8582000200
- Business address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,328,435
- in 8 filings, $4.3M under 10b5-1 plans
Net −$4,328,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- SAYER KEVIN R −$2.4M Executive Chair sold 8% of stake
- AUGUSTINOS NICHOLAS −$680K Director sold 22% of stake
- Stern Sadie −$649K EVP Chief People & Culture Off sold 6% of stake
- Sylvain Jereme M −$303K EVP, Chief Financal Officer sold 2% of stake
- Brown Michael Jon −$288K EVP Chief Legal Compliance Off sold 3% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-03 | SAYER KEVIN R Chairman, CEO & President | Sale | −500 | $382.48 | $191K | 107,353 |
| 2021-05-03 | SAYER KEVIN R Chairman, CEO & President | Sale | −300 | $384.91 | $115K | 107,053 |
| 2021-05-03 | SAYER KEVIN R Chairman, CEO & President | Sale | −1,331 | $386.04 | $514K | 105,722 |
| 2021-04-26 | Murphy Patrick Michael EVP, Chief Legal Officer | Sale | −500 | $415.83 | $208K | 19,241 |
| 2021-04-23 | Pacelli Steven Robert Managing Dir., Dexcom Ventures | Sale | −296 | $408.58 | $121K | 54,183 |
| 2021-04-23 | Pacelli Steven Robert Managing Dir., Dexcom Ventures | Sale | −436 | $410.69 | $179K | 53,747 |
| 2021-04-23 | Pacelli Steven Robert Managing Dir., Dexcom Ventures | Sale | −347 | $411.32 | $143K | 53,400 |
| 2021-04-15 | Flynn Paul R EVP, Global Revenue | Sale | −758 | $400.00 | $303K | 12,306 |
| 2021-04-05 | SAYER KEVIN R Chairman, CEO & President | Sale | −1,475 | $365.67 | $539K | 116,003 |
| 2021-04-05 | SAYER KEVIN R Chairman, CEO & President | Sale | −3,567 | $366.84 | $1.3M | 112,436 |
| 2021-04-05 | SAYER KEVIN R Chairman, CEO & President | Sale | −1,179 | $367.41 | $433K | 111,257 |
| 2021-03-26 | Murphy Patrick Michael EVP, Chief Legal Officer | Sale | −500 | $350.00 | $175K | 19,741 |
| 2021-03-23 | Pacelli Steven Robert Managing Dir., Dexcom Ventures | Sale | −18 | $352.88 | $6K | 55,540 |
| 2021-03-23 | Pacelli Steven Robert Managing Dir., Dexcom Ventures | Sale | −77 | $358.13 | $28K | 55,463 |
| 2021-03-23 | Pacelli Steven Robert Managing Dir., Dexcom Ventures | Sale | −589 | $360.36 | $212K | 54,874 |
| 2021-03-23 | Pacelli Steven Robert Managing Dir., Dexcom Ventures | Sale | −229 | $360.90 | $83K | 54,645 |
| 2021-03-23 | Pacelli Steven Robert Managing Dir., Dexcom Ventures | Sale | −166 | $362.30 | $60K | 54,479 |
| 2021-03-23 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −18 | $352.88 | $6K | 7,745 |
| 2021-03-23 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −74 | $358.13 | $27K | 7,671 |
| 2021-03-23 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −655 | $360.33 | $236K | 7,016 |
Page 39 of 40 · 785 trades